Protein profile

PA2991

soluble pyridine nucleotide transhydrogenase

Genome: NC_002516.2

Gene: PA2991 sthA sth Structure source: AlphaFold UniProt P57112
Amino acids 464
Annotations 8
Features 35
PDB binders 17
Druggability 0.273

Overview

Basic information about this protein and its source genome.

Accession
PA2991
Gene
PA2991 sthA sth
Status
annotated
Amino acids
464
Structure source
AlphaFold

Target profile

Computed evidence for target prioritization.

Human off-target
hit
Human identity (%)
42.857
Human E-value
6.46e-07
Gut microbiome off-target
hit
Essential (DEG)
Y
Localization
Cytoplasmic

Selected Druggability evidence

Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.

FPocket 0.273
Structure
Pocket

Sequence

Primary amino-acid sequence viewer.

Functional Annotations

Enzyme classification and Gene Ontology terms linked to this protein.

1 EC 7 GO

Enzyme Commission (EC)

1

Gene Ontology (GO)

7
  • GO:0005829 The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
  • GO:0004148 Catalysis of the reaction: N(6)-[(R)-dihydrolipoyl]-L-lysyl-[protein] + NAD+ = N(6)-[(R)-lipoyl]-L-lysyl-[protein] + NADH + H+.
  • GO:0050660 Binding to FAD, flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes, in either the oxidized form, FAD, or the reduced form, FADH2.
  • GO:0003957 Catalysis of the reaction: NADPH + NAD+ = NADP+ + NADH.
  • GO:0006103 The chemical reactions and pathways involving oxoglutarate, the dianion of 2-oxoglutaric acid. It is a key constituent of the TCA cycle and a key intermediate in amino-acid metabolism.
  • GO:0006739 The chemical reactions and pathways involving nicotinamide adenine dinucleotide phosphate (NADP+), a coenzyme that interconverts with its reduced form, NADPH, in many redox and biosynthetic reactions.
  • GO:0016491 Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.

Sequence Features

Domain/signature hits from InterPro and related databases.

35 records
Show feature table
Start End DB Term Name
262 276 PRINTS PR00411 Pyridine nucleotide disulphide reductase class-I signature
340 361 PRINTS PR00411 Pyridine nucleotide disulphide reductase class-I signature
305 312 PRINTS PR00411 Pyridine nucleotide disulphide reductase class-I signature
141 150 PRINTS PR00411 Pyridine nucleotide disulphide reductase class-I signature
177 202 PRINTS PR00411 Pyridine nucleotide disulphide reductase class-I signature
40 55 PRINTS PR00411 Pyridine nucleotide disulphide reductase class-I signature
405 420 PRINTS PR00411 Pyridine nucleotide disulphide reductase class-I signature
7 29 PRINTS PR00411 Pyridine nucleotide disulphide reductase class-I signature
430 450 PRINTS PR00411 Pyridine nucleotide disulphide reductase class-I signature
6 325 Pfam PF07992 Pyridine nucleotide-disulphide oxidoreductase
6 325 InterPro IPR023753 FAD/NAD(P)-binding domain
8 27 PRINTS PR00368 FAD-dependent pyridine nucleotide reductase signature
138 156 PRINTS PR00368 FAD-dependent pyridine nucleotide reductase signature
261 277 PRINTS PR00368 FAD-dependent pyridine nucleotide reductase signature
290 312 PRINTS PR00368 FAD-dependent pyridine nucleotide reductase signature
177 195 PRINTS PR00368 FAD-dependent pyridine nucleotide reductase signature
1 464 Hamap MF_00247 Soluble pyridine nucleotide transhydrogenase [sthA].
1 464 InterPro IPR022962 Soluble pyridine nucleotide transhydrogenase, gammaproteobacteria
157 275 FunFam G3DSA:3.50.50.60:FF:000008 Soluble pyridine nucleotide transhydrogenase
157 275 Gene3D G3DSA:3.50.50.60 -
157 275 InterPro IPR036188 FAD/NAD(P)-binding domain superfamily
343 463 FunFam G3DSA:3.30.390.30:FF:000002 Soluble pyridine nucleotide transhydrogenase
4 318 SUPERFAMILY SSF51905 FAD/NAD(P)-binding domain
4 318 InterPro IPR036188 FAD/NAD(P)-binding domain superfamily
2 459 PIRSF PIRSF000350 Hg-II_reductase_MerA
2 459 InterPro IPR001100 Pyridine nucleotide-disulphide oxidoreductase, class I
343 461 SUPERFAMILY SSF55424 FAD/NAD-linked reductases, dimerisation (C-terminal) domain
343 461 InterPro IPR016156 FAD/NAD-linked reductase, dimerisation domain superfamily
344 455 Pfam PF02852 Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain
344 455 InterPro IPR004099 Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain
343 463 Gene3D G3DSA:3.30.390.30 -
343 463 InterPro IPR016156 FAD/NAD-linked reductase, dimerisation domain superfamily
6 332 Gene3D G3DSA:3.50.50.60 -
6 332 InterPro IPR036188 FAD/NAD(P)-binding domain superfamily
5 456 PANTHER PTHR22912 DISULFIDE OXIDOREDUCTASE

3D Structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.

3D visualization script Full viewer

Loading 3D structure...

Legend High Medium Low

Structural evidence

0 + 1

Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold PA2991
AlphaFold full sequence Viewing
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer

Pockets (FPOCKET)

Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).

FPOCKET Sticks Spheres Surfaces Druggability Labels Zoom Positions
2 0.273
4 0.233

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

67 records

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
2JR Q389T8 351.5 Da LogP 5.55 TPSA 31.9 1 viol. ✓ Clean c1cc2c(cc[nH]2)cc1c3ncc(s3)C4(CCCCC4)N5CCCC5
BTB Q9A0E2 209.2 Da LogP -3.01 TPSA 104.4 ✓ Ro5 ✓ Clean C(CO)N(CCO)C(CO)(CO)CO
GCG Q389T8 723.9 Da LogP -4.58 TPSA 313.3 3 viol. ✓ Clean C(CCNC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@@H](C(=O)O…
JWZ Q389T8 607.9 Da LogP 3.63 TPSA 103.4 1 viol. ✓ Clean [H]/N=C(/N)\N1CCC(CC1)(CN(C)CCCN2CN(C3(C2=O)CCN…
M9J Q389T8 555.8 Da LogP 6.51 TPSA 45.1 2 viol. ✓ Clean c1cc2c(ccn2CC3CCCN3)cc1c4nc(c(s4)C5(CCCCC5)N6CC…
M9S Q389T8 434.7 Da LogP 5.77 TPSA 33.1 1 viol. ✓ Clean c1cc2c(ccn2C[C@@H]3CCCN3)cc1c4ncc(s4)C5(CCCCC5)…
M9Y Q389T8 597.8 Da LogP 6.91 TPSA 45.1 2 viol. ✓ Clean c1cc2c(ccn2CCC3CCNCC3)cc1c4nc(c(s4)C5(CCCCC5)N6…
MLT B4EEF2 134.1 Da LogP -1.09 TPSA 94.8 ✓ Ro5 ✓ Clean C([C@H](C(=O)O)O)C(=O)O
NHE P09622-2 207.3 Da LogP 0.80 TPSA 66.4 ✓ Ro5 ✓ Clean C1CCC(CC1)NCCS(=O)(=O)O
RBF Q9A0E2 376.4 Da LogP -1.72 TPSA 161.6 ✓ Ro5 ✓ Clean Cc1cc2c(cc1C)N(C3=NC(=O)NC(=O)C3=N2)C[C@@H]([C@…
RD0 Q389T8 462.7 Da LogP 6.41 TPSA 33.1 1 viol. ✓ Clean c1cc2c(ccn2CCC3CCNCC3)cc1c4ncc(s4)C5(CCCCC5)N6C…
RD7 Q389T8 463.7 Da LogP 4.93 TPSA 36.3 ✓ Ro5 ✓ Clean c1cc2c(ccn2CCN3CCNCC3)cc1c4ncc(s4)C5(CCCCC5)N6C…
WP5 Q389T8 373.2 Da LogP 4.08 TPSA 41.9 ✓ Ro5 ✓ Clean CC1=Nc2ccc(cc2[C@@H](N1CC(=O)OC)c3ccccc3)Br
WP6 Q389T8 346.9 Da LogP 6.00 TPSA 15.6 1 viol. ✓ Clean CC1=Nc2ccc(cc2[C@@H](N1Cc3ccccc3)c4ccccc4)Cl
WP7 Q389T8 463.0 Da LogP 4.85 TPSA 52.3 ✓ Ro5 ✓ Clean CC1=Nc2ccc(cc2[C@@H](N1CCN3CCN(CC3)C(=O)c4ccco4…
WPE Q389T8 393.9 Da LogP 4.82 TPSA 57.8 ✓ Ro5 ✓ Clean CC1=Nc2ccc(cc2[C@@H](N1CCNC(=O)c3ccco3)c4ccccc4…
WPF Q389T8 355.9 Da LogP 5.06 TPSA 18.8 1 viol. ✓ Clean Cc1ccc(cc1)[C@H]2c3cc(ccc3N=C(N2CCCN(C)C)C)Cl

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.